Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meimei Wu

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Cancer Medicine|June 26, 2025
STOX1 Isoform A Promotes Proliferation and Progression of Hepatocellular Carcinoma by Dual Mechanisms of Transcriptionally Upregulation of Cyclin B1 and Activation of ROS-Dependent PTEN/AKT1 SignalingChunlin Jiang, Chong Wang, Jian Ao, et al.
The Journal of Clinical Investigation|November 8, 2022
Molecular identification of bulbospinal ON neurons by GPER, which drives pain and morphine toleranceYingfu Jiao, Po Gao, Li Dong, et al.
Scientific Reports|June 24, 2026
Psoralidin enhances the sensitivity of breast cancer to cisplatin by targeting Nr1i2Meigong Zhong, Meimei Wu, Ruizhen Chen, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Cancer Medicine|June 26, 2025
STOX1 Isoform A Promotes Proliferation and Progression of Hepatocellular Carcinoma by Dual Mechanisms of Transcriptionally Upregulation of Cyclin B1 and Activation of ROS-Dependent PTEN/AKT1 SignalingChunlin Jiang, Chong Wang, Jian Ao, et al.
The Journal of Clinical Investigation|November 8, 2022
Molecular identification of bulbospinal ON neurons by GPER, which drives pain and morphine toleranceYingfu Jiao, Po Gao, Li Dong, et al.
Scientific Reports|June 24, 2026
Psoralidin enhances the sensitivity of breast cancer to cisplatin by targeting Nr1i2Meigong Zhong, Meimei Wu, Ruizhen Chen, et al.
Pageof 6